LON:VAL

ValiRx Final Earnings Results & Report

ValiRx logo
GBX 0.14 -0.02 (-10.00%)
As of 12:28 PM Eastern

ValiRx reported Final earnings on June 22, 2026. The company reported EPS of -GBX 0.54, while revenue was £30 thousand.

Earnings Announcement Details

Quarter
Final
Report Date
Time
Before Market Opens

ValiRx EPS Results

Actual EPS
-GBX 0.54
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

ValiRx Revenue Results

Actual Revenue
£30 thousand
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

ValiRx Final Earnings FAQ

ValiRx (LON:VAL) reported earnings of -GBX 0.54 per share for Final. The report was announced on Monday, June 22, 2026.

ValiRx reported revenue of £30 thousand for Final.

ValiRx Earnings Headlines

Update on Ambrose Healthcare shareholding
The $40 trillion number nobody won on Tuesday will touch
Democrats took the House and Senate on election night, but the $40 trillion national debt and the $1 trillion a year in interest on it didn't change. Central banks bought 863 tonnes of gold in 2025 and another 289 tonnes in the second quarter of this year. Gold broke $5,000 and had its best year since 1979 in 2025. Wall Street's biggest bank forecasts gold above $6,000 by early 2027.tc pixel
See More ValiRx Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ValiRx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ValiRx and other key companies, straight to your email.

About ValiRx

ValiRx (LON:VAL) accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.

View ValiRx Profile